Ketolides Global Market Report 2025

Description

Ketolides, a class of antibiotics within the macrolide group, are derived from erythromycin, a 14-membered macrolide. They are created by replacing the cladinose sugar with a keto-group and incorporating a cyclic carbamate group into the lactone ring structure. Ketolides exert their antibiotic effects by inhibiting protein synthesis, thus impeding the production of essential proteins vital for bacterial maintenance and survival.

The primary drugs falling under the ketolides category include telithromycin, cethromycin, and solithromycin. Telithromycin, a semi-synthetic antibiotic of the ketolide class, is deployed in the treatment of respiratory tract infections. These antibiotics find application in a range of conditions, including bronchitis, pneumonia, sinusitis, tonsillitis, and pharyngitis. They target various microorganisms such as Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, Chlamydophila pneumoniae, and Mycoplasma pneumoniae. Ketolides are distributed through diverse channels, including hospital pharmacies, retail pharmacies, online pharmacies, and others.

The ketolides market research report is one of a series of new reports from The Business Research Company that provides ketolides market statistics, including ketolides industry global market size, regional shares, competitors with a ketolides market share, detailed ketolides market segments, market trends and opportunities and any further data you may need to thrive in the ketolides industry. This ketolides market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The ketolides market size has grown steadily in recent years. It will grow from $3.22 billion in 2024 to $3.35 billion in 2025 at a compound annual growth rate (CAGR) of 4.1%. The growth in the historic period can be attributed to increasing prevalence of infectious diseases, growing consumption of antibiotics, demand for effective and convenient treatments for infectious diseases, government initiatives.

The ketolides market size is expected to see steady growth in the next few years. It will grow to $4.04 billion in 2029 at a compound annual growth rate (CAGR) of 4.8%. The growth in the forecast period can be attributed to investments in research and development activities for ketolides, growing number of screening programs for infectious diseases, incremental healthcare spending growing awareness of antimicrobial stewardship. Major trends in the forecast period include innovative treatments for infectious diseases, development of targeted therapies, advancements in diagnosis and treatment of infectious diseases, development of new ketolide formulations.

The rising prevalence of infectious diseases is expected to drive the growth of the ketolides market. Infectious diseases, caused by pathogens such as bacteria, viruses, fungi, or parasites, can spread from person to person, leading to a variety of health complications. Tuberculosis (TB) is one example of an infectious disease for which ketolides are being evaluated due to their potent intracellular activity, which is crucial for treating TB. For instance, in February 2024, GOV.UK reported that cases of tuberculosis in England increased by 10.7% in 2023, rising from 4,380 in 2022 to 4,850. As infectious diseases like tuberculosis continue to rise, the demand for effective treatments, including ketolides, is expected to grow.

The expansion of the healthcare industry is expected to drive the growth of the ketolides market. The healthcare industry encompasses various sectors focused on curing, preventing, rehabilitating, and providing palliative care for patients. As the healthcare sector grows, it plays a critical role in the development and distribution of ketolides by supporting research, clinical trials, and regulatory processes to assess their safety and effectiveness. Additionally, the healthcare industry ensures that ketolides are administered securely and efficiently to patients. For example, in May 2023, the American Health Care Association reported an increase in the number of hospitals in the U.S., rising from 6,093 in 2022 to 6,129. This growth in healthcare infrastructure supports the ongoing development and adoption of treatments like ketolides, thereby fueling market expansion.

The leading companies within the ketolides market are strongly committed to pioneering innovative drugs and treatment approaches, with the aim of gaining a competitive edge and maintaining their market position. For instance, AliquantumRx Inc., a US-based biotechnical research company, which, in June 2023, celebrated the approval of a patent by the United States Patent and Trademark Office (USPTO), a key agency under the Department of Commerce. This patent, titled 'salts and polymorphs of cethromycin for the treatment of bacterial and protozoan disease,' pertains to cethromycin, a ketolide antibiotic that demonstrates effectiveness against various infectious diseases caused by both bacteria and protozoa. These conditions encompass malaria, babesiosis, toxoplasmosis, diarrhea, and more. Notably, this newly granted patent significantly expands the possibilities for the use of cethromycin, potentially lowering the barriers to its commercialization and facilitating its application in treating a broader range of diseases.

The ketolides market is witnessing growth, primarily attributed to the increasing prevalence of chronic sinusitis. Chronic sinusitis is characterized by persistent inflammation in the sinus cavities around the nasal passages. Ketolides, a class of antibiotics with immunomodulatory and anti-inflammatory properties, find application in the treatment of various medical conditions. Given that chronic sinusitis involves inflammation of the sinuses, ketolides play a role in mitigating this inflammation and alleviating associated symptoms. For example, data from the US-based Centers for Disease Control and Prevention (CDC) as of January 2022 indicated that approximately 11.6% of adults in the United States had received diagnoses of sinusitis. Consequently, the expanding occurrence of chronic sinusitis serves as a driving force behind the growth of the ketolides market.

Major companies operating in the ketolides market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Bayer AG, Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca PLC, Abbott Laboratories, GSK PLC, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Daiichi Sankyo Company Limited, Shionogi & Company Limited, Dr. Reddys Laboratories Ltd., Taisho Pharmaceutical Co. Ltd., Glenmark Pharmaceuticals Ltd., Zhejiang Yongtai Technology Co. Ltd., Corden Pharma GmbH, Optimer Pharmaceuticals Inc., Vivimed Labs Limited, Wockhardt Ltd., Advanced Life Sciences Holdings Inc.

North America was the largest region in the ketolides market in 2024. The regions covered in ketolides report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the ketolides market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The ketolides market consists of sales of solithera and ketek, arylalkyl and macrolactone rings. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Ketolides Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on ketolides market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for ketolides ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The ketolides market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Drug Type: Telithromycin; Cethromycin; Solithromycin
2) By Indication: Bronchitis; Pneumonia; Sinusitis; Tonsillitis Or Pharyngitis
3) By Microorganism: Streptococcus Pneumoniae; Haemophilus Influenzae; Moraxella Catarrhalis; Chlamydophila Pneumoniae; Mycoplasma Pneumoniae
4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies; Other Distribution Channels
Companies Mentioned: Pfizer Inc.; F. Hoffmann-La Roche Ltd.; Merck & Co. Inc.; Bayer AG; Novartis AG
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r28380

1. Executive Summary

2. Ketolides Market Characteristics

3. Ketolides Market Trends And Strategies

4. Ketolides Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Ketolides Growth Analysis And Strategic Analysis Framework

5.1. Global Ketolides PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Ketolides Market Growth Rate Analysis
5.4. Global Ketolides Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Ketolides Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Ketolides Total Addressable Market (TAM)

6. Ketolides Market Segmentation

6.1. Global Ketolides Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Telithromycin
Cethromycin
Solithromycin
6.2. Global Ketolides Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Bronchitis
Pneumonia
Sinusitis
Tonsillitis Or Pharyngitis
6.3. Global Ketolides Market, Segmentation By Microorganism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Streptococcus Pneumoniae
Haemophilus Influenzae
Moraxella Catarrhalis
Chlamydophila Pneumoniae
Mycoplasma Pneumoniae
6.4. Global Ketolides Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Other Distribution Channels

7. Ketolides Market Regional And Country Analysis

7.1. Global Ketolides Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Ketolides Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Ketolides Market

8.1. Asia-Pacific Ketolides Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Ketolides Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Ketolides Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Ketolides Market, Segmentation By Microorganism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Ketolides Market

9.1. China Ketolides Market Overview
9.2. China Ketolides Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Ketolides Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Ketolides Market, Segmentation By Microorganism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Ketolides Market

10.1. India Ketolides Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Ketolides Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Ketolides Market, Segmentation By Microorganism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Ketolides Market

11.1. Japan Ketolides Market Overview
11.2. Japan Ketolides Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Ketolides Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Ketolides Market, Segmentation By Microorganism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Ketolides Market

12.1. Australia Ketolides Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Ketolides Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Ketolides Market, Segmentation By Microorganism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Ketolides Market

13.1. Indonesia Ketolides Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Ketolides Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Ketolides Market, Segmentation By Microorganism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Ketolides Market

14.1. South Korea Ketolides Market Overview
14.2. South Korea Ketolides Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Ketolides Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Ketolides Market, Segmentation By Microorganism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Ketolides Market

15.1. Western Europe Ketolides Market Overview
15.2. Western Europe Ketolides Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Ketolides Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Ketolides Market, Segmentation By Microorganism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Ketolides Market

16.1. UK Ketolides Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Ketolides Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Ketolides Market, Segmentation By Microorganism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Ketolides Market

17.1. Germany Ketolides Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Ketolides Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Ketolides Market, Segmentation By Microorganism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Ketolides Market

18.1. France Ketolides Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Ketolides Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Ketolides Market, Segmentation By Microorganism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Ketolides Market

19.1. Italy Ketolides Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Ketolides Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Ketolides Market, Segmentation By Microorganism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Ketolides Market

20.1. Spain Ketolides Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Ketolides Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Ketolides Market, Segmentation By Microorganism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Ketolides Market

21.1. Eastern Europe Ketolides Market Overview
21.2. Eastern Europe Ketolides Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Ketolides Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Ketolides Market, Segmentation By Microorganism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Ketolides Market

22.1. Russia Ketolides Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Ketolides Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Ketolides Market, Segmentation By Microorganism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Ketolides Market

23.1. North America Ketolides Market Overview
23.2. North America Ketolides Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Ketolides Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Ketolides Market, Segmentation By Microorganism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Ketolides Market

24.1. USA Ketolides Market Overview
24.2. USA Ketolides Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Ketolides Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Ketolides Market, Segmentation By Microorganism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Ketolides Market

25.1. Canada Ketolides Market Overview
25.2. Canada Ketolides Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Ketolides Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Ketolides Market, Segmentation By Microorganism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Ketolides Market

26.1. South America Ketolides Market Overview
26.2. South America Ketolides Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Ketolides Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Ketolides Market, Segmentation By Microorganism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Ketolides Market

27.1. Brazil Ketolides Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Ketolides Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Ketolides Market, Segmentation By Microorganism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Ketolides Market

28.1. Middle East Ketolides Market Overview
28.2. Middle East Ketolides Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Ketolides Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Ketolides Market, Segmentation By Microorganism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Ketolides Market

29.1. Africa Ketolides Market Overview
29.2. Africa Ketolides Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Ketolides Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Ketolides Market, Segmentation By Microorganism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Ketolides Market Competitive Landscape And Company Profiles

30.1. Ketolides Market Competitive Landscape
30.2. Ketolides Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

31. Ketolides Market Other Major And Innovative Companies

31.1. Sanofi S.A.
31.2. Bristol-Myers Squibb Company
31.3. AstraZeneca PLC
31.4. Abbott Laboratories
31.5. GSK PLC
31.6. Takeda Pharmaceutical Company Limited
31.7. Eli Lilly and Company
31.8. Teva Pharmaceutical Industries Ltd.
31.9. Astellas Pharma Inc.
31.10. Daiichi Sankyo Company Limited
31.11. Shionogi & Company Limited
31.12. Dr. Reddys Laboratories Ltd.
31.13. Taisho Pharmaceutical Co. Ltd.
31.14. Glenmark Pharmaceuticals Ltd.
31.15. Zhejiang Yongtai Technology Co. Ltd.

32. Global Ketolides Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Ketolides Market

34. Recent Developments In The Ketolides Market

35. Ketolides Market High Potential Countries, Segments and Strategies

35.1 Ketolides Market In 2029 - Countries Offering Most New Opportunities
35.2 Ketolides Market In 2029 - Segments Offering Most New Opportunities
35.3 Ketolides Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer